Viewing Study NCT02315703


Ignite Creation Date: 2025-12-24 @ 7:30 PM
Ignite Modification Date: 2026-03-01 @ 4:13 PM
Study NCT ID: NCT02315703
Status: COMPLETED
Last Update Posted: 2025-02-04
First Post: 2014-12-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention
Sponsor: Janssen Vaccines & Prevention B.V.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR106152
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View
None NETWORK View
None OTHER View
None NETWORK View